Name: | Description: | Size: | Format: | |
---|---|---|---|---|
2.54 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Although the plants of the genus Euphorbia are largely exploited by therapists in Morocco,
the composition and antibacterial activities of propolis from these plants are still unknown. To
address this gap, this study aimed to characterize the pollen type, the volatile compounds, and the
phenolic and mineral profiles of three Euphorbia propolis samples collected in Morocco and evaluate
their antimicrobial activities. The minimum inhibitory concentration of the propolis samples was
determined by the microdilution method, and the anti-adherence activity was evaluated by the crystal
violet assay. The examination of anti-quorum-sensing proprieties was performed using the biosensor
Chromobacterium violaceum CV026. Pollen analysis revealed that Euphorbia resinifera pollen dominated
in the P1 sample (58%), while E. officinarum pollen dominated in the P2 and P3 samples (44%). The
volatile compounds were primarily composed of monoterpene hydrocarbons, constituting 35% in P1
and 31% in P2, with α-pinene being the major component in both cases, at 16% in P1 and 15% in P2.
Calcium (Ca) was the predominant mineral element in both E. resinifera (P1) and E. officinarum (P2
and P3) propolis samples. Higher levels of phenols, flavonoids and dihydroflavonoids were detected
in the E. officinarum P2 sample. The minimum inhibitory concentration (MIC) value ranged from
50 to 450 µL/mL against Gram-positive and Gram-negative bacteria. Euphorbia propolis displayed
the ability to inhibit quorum sensing in the biosensor C. violaceum CV026 and disrupted bacterial
biofilm formation, including that of resistant bacterial pathogens. In summary, the current study
evidences the potential use of E. officinarum propolis (P2 and P3) to combat important features of
resistant pathogenic bacteria, such as quorum sensing and biofilm formation.
Description
Keywords
Volatiles Euphorbia propolis Pollen analysis Quorum sensing Anti-biofilm Methicillin-resistant Staphylococcus aureus
Citation
Antibiotics 13 (3): 230 (2024)
Publisher
MDPI